This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Earnings Short-Squeeze Trades

Stocks in this article: GIII UNFI MFRM MIND CYBX

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cyberonics

My final earnings short-squeeze play is medical equipment and supplies player Cyberonics (CYBX), which is set to release numbers on Wednesday before the market open. This is neuromodulation company engages in the design, development, sale, and marketing of implantable medical devices that provide vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. Wall Street analysts, on average, expect Cyberonics to report revenue of $56.61 million on earnings of 35 cents per share.

If you're looking for a stock that's been uptrending pretty strong heading into its earnings report, then make sure to check out shares of Cyberonics. This stock is up 13% so far in 2012, and its currently trending just a few points off of its 52-week high of $40.29 a share. The current short interest as a percentage of the float for Cyberonics is rather high at 9.3%. That means that out of the 23.45 million shares in the tradable float, 2.44 million are sold short by the bears.

From a technical perspective, CYBX is currently above its 200-day moving average and below its 50-day moving average, which is neutral trendwise. This stock has soared during the last six months, from a low of $23 to a recent high of $40.29 a share. During that run, shares of CYBX have mostly made higher highs and higher lows, which is bullish technical price action. That said, during the last three months, CYBX has been moving sideways between $40.29 on the upside and $35 on the downside. A move outside of that range post-earnings should setup the next major trend for CYBX.

If you're bullish on CYBX, I would wait until after they report and look for long-biased trades if this stock triggers a major break out above $39.48 to $40.29 a share with high-volume. Look for volume on that move that's near or above its three-month average volume of 195,305 shares. If we get that move, then CYBX will be trading in new 52-week high territory, and the stock could hit $45 to $50 in the near future.

I would simply avoid CYBX or look for short-biased trades if it fails to trigger that breakout, and then drops below some near-term support at $37.23 to $35.75 a share with high-volume. If we get that action, then I would target a drop down toward $34 to possibly its 200-day moving average of $32.96 a share if the bears spark a major selloff post-earnings.

To see more potential earnings short squeeze plays, check out the Earnings Short Squeeze Plays portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs